RHJA
STAA icon

Rice Hall James & Associates’s STAAR Surgical STAA Stock Holding History

Rice Hall James & Associates’s Portfolio STAA Stock Details STAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-47,365
Closed -$1.15M – 254
2024
Q4 		$1.15M Sell
47,365
-987
-2% -$28.2K 0.06% 197
2024
Q3 		$1.8M Sell
48,352
-762
-2% -$28.4K 0.1% 180
2024
Q2 		$2.34M Sell
49,114
-451
-0.9% -$19.8K 0.14% 152
2024
Q1 		$1.9M Sell
49,565
-3
-0% -$98 0.11% 179
2023
Q4 		$1.55M Sell
49,568
-12,835
-21% -$461K 0.09% 195
2023
Q3 		$2.51M Sell
62,403
-517
-0.8% -$24.2K 0.16% 142
2023
Q2 		$3.31M Sell
62,920
-10,162
-14% -$619K 0.19% 126
2023
Q1 		$4.67M Sell
73,082
-69
-0.1% -$4.5K 0.27% 90
2022
Q4 		$3.55M Sell
73,151
-926
-1% -$58.1K 0.2% 121
2022
Q3 		$5.23M Buy
74,077
+6,290
+9% +$538K 0.3% 78
2022
Q2 		$4.81M Buy
67,787
+33,792
+99% +$2.18M 0.23% 90
2022
Q1 		$2.72M Buy
+33,995
New +$2.53M 0.11% 180
2021
Q4 		– Sell
-15,775
Closed -$2.03M – 316
2021
Q3 		$2.03M Sell
15,775
-5,476
-26% -$766K 0.07% 200
2021
Q2 		$3.24M Sell
21,251
-685
-3% -$90.2K 0.12% 134
2021
Q1 		$2.31M Sell
21,936
-12,413
-36% -$1.24M 0.08% 192
2020
Q4 		$2.72M Sell
34,349
-1,359
-4% -$99.4K 0.1% 150
2020
Q3 		$2.02M Sell
35,708
-7,188
-17% -$387K 0.08% 166
2020
Q2 		$2.64M Sell
42,896
-21,642
-34% -$884K 0.11% 131
2020
Q1 		$2.08M Sell
64,538
-1,434
-2% -$48.3K 0.12% 138
2019
Q4 		$2.32M Sell
65,972
-1,141
-2% -$37.6K 0.08% 153
2019
Q3 		$1.73M Sell
67,113
-3,716
-5% -$113K 0.06% 187
2019
Q2 		$2.08M Buy
70,829
+24,385
+53% +$704K 0.07% 176
2019
Q1 		$1.59M Sell
46,444
-2,075
-4% -$73.4K 0.05% 222
2018
Q4 		$1.55M Buy
48,519
+4,766
+11% +$186K 0.06% 211
2018
Q3 		$2.1M Sell
43,753
-33,988
-44% -$1.39M 0.08% 167
2018
Q2 		$2.41M Sell
77,741
-69,646
-47% -$1.63M 0.09% 165
2018
Q1 		$2.18M Sell
147,387
-10,372
-7% -$162K 0.09% 168
2017
Q4 		$2.44M Sell
157,759
-7,336
-4% -$109K 0.1% 169
2017
Q3 		$2.06M Buy
+165,095
New +$1.84M 0.09% 190

Other funds holding STAA

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $20.1B AUM 26.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
YC
Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Rice Hall James & Associates's STAA Position: Q1 2025 in Review

Rice Hall James & Associates sold out of STAAR Surgical (STAA) in Q1 2025, closing a stake of 47,365 shares — an estimated $1.15M sold.

Rice Hall James & Associates first reported a position in STAA in Q3 2017 and held it in 29 quarters. The position peaked at $5.23M in Q3 2022. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2025.

  • Rice Hall James & Associates reported no remaining STAAR Surgical position as of Q1 2025 after selling out during the quarter.
  • Rice Hall James & Associates sold 47,365 STAAR Surgical shares in Q1 2025, an estimated $1.15M.
  • Rice Hall James & Associates first reported a position in STAAR Surgical in Q3 2017 and held it in 29 quarters.
  • Rice Hall James & Associates's STAAR Surgical position peaked at $5.23M in Q3 2022.
  • 185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2025.

Based on Rice Hall James & Associates's 13F filing for Q1 2025, filed 1 May 2025.